dr. isaacs discusses antibody drug conjugates in tnbc
Published 6 years ago • 110 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
0:58
dr. isaacs discusses sacituzumab govitecan in tnbc
-
6:17
antibody-drug conjugates in tnbc: sacituzumab govitecan
-
6:20
antibody-drug conjugates for tnbc
-
6:44
antibody-drug conjugates in treating tnbc
-
1:15
dr. isaacs discusses the future of treatment for her2 breast cancer
-
1:38
dr. hart on antibody-drug conjugates in her2 breast cancer
-
1:31
dr. andreadis on antibody-drug conjugates in dlbcl
-
0:57
dr. cobleigh on antibody-drug conjugates in development in her2 breast cancer
-
25:46
antibody drug conjugates present and future applications in breast cancer
-
41:17
estrogen dominance and the microbiome
-
4:40
elizabeth bright p2 | prostate needs iodine …especially in puberty, girls need even more
-
2:20
dr vahdat on recent data on adcs in metastatic tnbc
-
9:19
rate and class effect of ild with antibody drug conjugates
-
0:52
dr. julie gralow discusses the antibody drug conjugate t-dm1 for breast cancer
-
2:38
potential new drugs with activity in metastatic tnbc
-
1:06
dr. edith perez on the antibody-drug conjugate t-dm1
-
2:02
dr. soliman the utility of adcs in breast cancer
-
13:22
treatment talks | antibody drug conjugates
-
2:49
(overview) new biomarkers in a novel antibody-drug conjugate for triple negative breast cancer
-
10:57
metastatic triple negative breast cancer antibody-drug conjugate treatment options
-
4:19
antibody drug conjugates for triple negative breast cancer: targeting positive in the negative
-
1:06
dr. wong on antibody-drug conjugate research in multiple myeloma